Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Neximmune Inc NEXI

Healthcare Biotechnology
NexImmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. Its product candidates include NEXI-001 in acute myeloid leukemia (AML); NEXI-002 in multiple myeloma (MM), and NEXI-003, a solid tumor product candidate for Human... see more

Bullboard (PINL:NEXI)

View:
1 2 3 Next
Post by MikeTesteron Aug 03, 2024 2:29pm

NexImmune, Inc. (NASDAQ:NEXI): A Promising Biotech Poised fo

https://beyondspx.com/2024/08/03/neximmune-inc-nasdaqnexi-a-promising-biotech-poised-for-transformation/
36
Post by whytestockson Feb 06, 2024 9:00pm

NexImmune Announces Closing of $3.67 Million Registered Dire

BREAKING NEWS: $NEXI NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGAITHERSBURG, Md., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. ...more  
66
Post by whytestockson Feb 02, 2024 6:15pm

NexImmune Announces $3.67 Million Registered Direct Offering

Just In: $NEXI NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGAITHERSBURG, Md., Feb. 02, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology ...more  
59
Comment by Iseneschalon Feb 02, 2024 3:11pm

RE:NEXI....hard to keep on top of things....

the previous one was for raising upto 50M, today it is a direct offering where they offered unregistered warrants which will bring the price down because as soon those get exercised, company has to ...more  
43
Discussion
Post by Iseneschalon Feb 02, 2024 3:10pm

NEXI....hard to keep on top of things....

The 8K is about terminating an old agreement date June 2022 between Cantor and Nexi to raise upto 50 M cash , so the company is not liquidating
69
Discussion
Comment by Iseneschalon Feb 02, 2024 2:45pm

RE:NEXI....The P.O is terminated

Inline XBRL Viewer (sec.gov)
31
Discussion
Comment by Iseneschalon Feb 02, 2024 2:09pm

RE:NEXI.....please not all at once....Sub $13 now....

Well here it is Flolks ...The Gomer Pyle moment P.O announce...just now Hymen Slimers....LoL Very sneaky
28
Discussion
Post by Nibinatoron Jan 30, 2024 5:27pm

MARK

Oh by the way have you remarked what microsoft lended to REMARK
77
Post by Iseneschalon Jan 30, 2024 3:38pm

NEXI.....please not all at once....Sub $13 now....

as predicted Wait for the announcement It's going to be a "Gomer Pyle" moment ; )
74
Discussion
Post by Iseneschalon Jan 30, 2024 3:10pm

NEXI....sub $15...next support is $13

I tell ya...this is going to surprise a whole lot of people Total cr8p
59
1 2 3 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities